SWOG S1500 - Randomized Phase II Trial Efficacy assessment of multiple MET kinase inhibitors in metastatic PRCC

SWOG S1500 - Randomized Phase II Trial Efficacy assessment of multiple MET kinase inhibitors in metastatic PRCC

User Photo
kidneycancer

2 years
54 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Brian M. Shuch, MD Yale School of Medicine, discusses the SWOG S1500 - Randomized Phase II Trial Efficacy assessment of multiple MET kinase inhibitors in metastatic PRCC at Kidney Cancer Association 2017 in Miami.
Up Next Autoplay
>